- Home
- DAWN vs FND Comparison
DAWN vs FND Comparison
Compare DAWN & FND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- FND
- Stock Information
- Founded
- DAWN 2018
- FND 2000
- Country
- DAWN United States
- FND United States
- Employees
- DAWN N/A
- FND N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- FND RETAIL: Building Materials
- Sector
- DAWN Health Care
- FND Consumer Discretionary
- Exchange
- DAWN Nasdaq
- FND Nasdaq
- Market Cap
- DAWN 1.3B
- FND 10.9B
- IPO Year
- DAWN 2021
- FND 2017
- Fundamental
- Price
- DAWN $12.79
- FND $101.53
- Analyst Decision
- DAWN Strong Buy
- FND Hold
- Analyst Count
- DAWN 7
- FND 19
- Target Price
- DAWN $36.17
- FND $104.37
- AVG Volume (30 Days)
- DAWN 937.9K
- FND 1.4M
- Earning Date
- DAWN 10-30-2024
- FND 10-30-2024
- Dividend Yield
- DAWN N/A
- FND N/A
- EPS Growth
- DAWN N/A
- FND N/A
- EPS
- DAWN N/A
- FND 1.80
- Revenue
- DAWN $101,953,000.00
- FND $4,396,475,000.00
- Revenue This Year
- DAWN N/A
- FND $1.27
- Revenue Next Year
- DAWN $36.10
- FND $9.71
- P/E Ratio
- DAWN N/A
- FND $56.30
- Revenue Growth
- DAWN N/A
- FND N/A
- 52 Week Low
- DAWN $11.94
- FND $89.06
- 52 Week High
- DAWN $18.07
- FND $135.67
- Technical
- Relative Strength Index (RSI)
- DAWN 39.97
- FND 36.10
- Support Level
- DAWN $12.26
- FND $97.09
- Resistance Level
- DAWN $12.81
- FND $110.76
- Average True Range (ATR)
- DAWN 0.52
- FND 3.72
- MACD
- DAWN -0.05
- FND -1.61
- Stochastic Oscillator
- DAWN 28.94
- FND 8.63
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.
About FND Floor & Decor Holdings Inc.
Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site.